A randomised, open-labelstudy of insulin glargine or neutral protamine Hagedorn insulin in Chinese paediatric patients with type 1 diabetes mellitus

BACKGROUND: We aimed to describe the safety and efficacy of insulin glargine in Chinese paediatric patients with type 1 diabetes mellitus (T1DM). Neutral protamine Hagedorn (NPH) insulin was the reference therapy. METHODS: This open-label, randomised, Phase III study was conducted at 10 sites in Chi...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Min, Zhou, Zhiguang, Yan, Jinhua, Li, Pin, Song, Wenhui, Fu, Junfen, Chen, Xiaobo, Zhao, Weigang, Xi, Li, Luo, Xiaoping, Sha, Liang, Deng, Xueyuan, Gong, Chunxiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124261/
https://www.ncbi.nlm.nih.gov/pubmed/27887605
http://dx.doi.org/10.1186/s12902-016-0146-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124261/
https://www.ncbi.nlm.nih.gov/pubmed/27887605
http://dx.doi.org/10.1186/s12902-016-0146-2

Ejemplares similares